Lacher Sarah E, Skagen Kasse, Veit Joachim, Dalton Rachel, Woodahl Erica L
Department of Biomedical and Pharmaceutical Sciences (S.E.L., K.S., J.V., R.D., E.L.W.), Center for Environmental Health Sciences (S.E.L.), and Center for Biomolecular Structure and Dynamics, University of Montana, Missoula, Montana (E.L.W.).
Department of Biomedical and Pharmaceutical Sciences (S.E.L., K.S., J.V., R.D., E.L.W.), Center for Environmental Health Sciences (S.E.L.), and Center for Biomolecular Structure and Dynamics, University of Montana, Missoula, Montana (E.L.W.)
J Pharmacol Exp Ther. 2015 Oct;355(1):99-107. doi: 10.1124/jpet.115.226373. Epub 2015 Aug 13.
P-glycoprotein (P-gp) has been associated with a number of neurodegenerative diseases, including Parkinson's disease, although the mechanisms remain unclear. Altered transport of neurotoxic pesticides has been proposed in Parkinson's disease, but it is unknown whether these pesticides are P-gp substrates. We used three in vitro transport models, stimulation of ATPase activity, xenobiotic-induced cytotoxicity, and inhibition of rhodamine-123 efflux, to evaluate P-gp transport of diazinon, dieldrin, endosulfan, ivermectin, maneb, 1-methyl-4-phenyl-4-phenylpyridinium ion (MPP(+)), and rotenone. Diazinon and rotenone stimulated ATPase activity in P-gp-expressing membranes, with Vmax values of 22.4 ± 2.1 and 16.8 ± 1.0 nmol inorganic phosphate/min per mg protein, respectively, and Km values of 9.72 ± 3.91 and 1.62 ± 0.51 µM, respectively, compared with the P-gp substrate verapamil, with a Vmax of 20.8 ± 0.7 nmol inorganic phosphate/min per mg protein and Km of 0.871 ± 0.172 μM. None of the other pesticides stimulated ATPase activity. We observed an increased resistance to MPP(+) and rotenone in LLC-MDR1-WT cells compared with LLC-vector cells, with 15.4- and 2.2-fold increases in EC50 values, respectively. The resistance was reversed in the presence of the P-gp inhibitor verapamil. None of the other pesticides displayed differential cytotoxicity. Ivermectin was the only pesticide to inhibit P-gp transport of rhodamine-123, with an IC50 of 0.249 ± 0.048 μM. Our data demonstrate that dieldrin, endosulfan, and maneb are not P-gp substrates or inhibitors. We identified diazinon, MPP(+), and rotenone as P-gp substrates, although further investigation is needed to understand the role of P-gp transport in their disposition in vivo and associations with Parkinson's disease.
P-糖蛋白(P-gp)与包括帕金森病在内的多种神经退行性疾病有关,但其机制尚不清楚。帕金森病中已提出神经毒性农药的转运发生改变,但这些农药是否为P-gp底物尚不清楚。我们使用了三种体外转运模型,即ATP酶活性刺激、外源性物质诱导的细胞毒性以及罗丹明-123外排抑制,来评估二嗪农、狄氏剂、硫丹、伊维菌素、代森锰锌、1-甲基-4-苯基-4-苯基吡啶离子(MPP(+))和鱼藤酮的P-gp转运。二嗪农和鱼藤酮刺激了表达P-gp的膜中的ATP酶活性,Vmax值分别为22.4±2.1和16.8±1.0 nmol无机磷酸盐/分钟每毫克蛋白质,Km值分别为9.72±3.91和1.62±0.51 μM,与P-gp底物维拉帕米相比,维拉帕米的Vmax为20.8±0.7 nmol无机磷酸盐/分钟每毫克蛋白质,Km为0.871±0.172 μM。其他农药均未刺激ATP酶活性。我们观察到,与LLC-载体细胞相比,LLC-MDR1-WT细胞对MPP(+)和鱼藤酮的抗性增加,EC50值分别增加了15.4倍和2.2倍。在P-gp抑制剂维拉帕米存在的情况下,这种抗性被逆转。其他农药均未表现出差异细胞毒性。伊维菌素是唯一一种抑制罗丹明-123的P-gp转运的农药,IC50为0.249±0.048 μM。我们的数据表明,狄氏剂、硫丹和代森锰锌不是P-gp底物或抑制剂。我们确定二嗪农、MPP(+)和鱼藤酮为P-gp底物,尽管需要进一步研究以了解P-gp转运在它们体内处置中的作用以及与帕金森病的关联。